Family Practice NewsFish oil pills do not reduce fractures in healthy seniors: VITALSeptember 14, 2022Mixed TopicsEndocrinologyWomen's HealthMen's HealthRheumatology
Family Practice NewsPossible sex differences found in response to first treatments for early RASeptember 13, 2022Rheumatology
Family Practice NewsHip fractures likely to double by 2050 as population agesSeptember 13, 2022EndocrinologyRheumatologyGeriatrics
Family Practice NewsCrystal bone algorithm predicts early fractures, uses ICD codesSeptember 12, 2022EndocrinologyRheumatology
Family Practice NewsCOX-2, TNF inhibitor combo appear to have limited role in reducing axSpA spinal damage progressionSeptember 12, 2022Rheumatology
Family Practice NewsBimekizumab effective for axSpA with or without prior TNFi treatmentSeptember 9, 2022Rheumatology
Family Practice NewsShould patients with PsA or ankylosing spondylitis with axial disease be ‘lumped’ or ‘split’?September 8, 2022Rheumatology
Family Practice NewsInhaled, systemic steroids linked to changes in brain structureAugust 31, 2022NeurologyRheumatologyPulmonologyMental HealthEndocrinologyMixed TopicsAsthma
Family Practice NewsMedicare drug changes ought to benefit rheumatology patientsAugust 31, 2022Business of MedicineRheumatology
Family Practice NewsAutoimmune disease patients’ waxing, waning response to COVID vaccination studied in-depthAugust 29, 2022COVID-19 UpdatesVaccinesGastroenterologyRheumatologyInfectious DiseasesDermatology
Family Practice NewsRivaroxaban outmatched by VKAs for AFib in rheumatic heart diseaseAugust 28, 2022CardiologyRheumatologyMixed Topics
Family Practice NewsALL-HEART: No benefit of allopurinol in ischemic heart diseaseAugust 28, 2022RheumatologyCardiology
Family Practice NewsCannabis for pain linked to slight risk for arrhythmiaAugust 27, 2022CardiologyPainOncologyRheumatologyMixed Topics
Family Practice NewsOlokizumab proves noninferior to adalimumab for RA in phase 3 trialAugust 24, 2022Rheumatology